カテゴリー： GlobalInfoResearch, 世界, 産業機械/建設

合成血液代替物及び血液製剤の世界市場2022：ヒト血液、動物血液、微生物、合成高分子、幹細胞、その他

◆英語タイトル：Global Synthetic Blood Substitutes and Blood Product Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22NO17014 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年11月（※2025年版があります。お問い合わせください。） ◆ページ数：115 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：産業機器

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

合成血液代替物及び血液製剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の合成血液代替物及び血液製剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

合成血液代替物及び血液製剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ヒト血液、動物血液、微生物、合成高分子、幹細胞、その他

用途別セグメントは次のように区分されます。
・病院・診療所、血液銀行、その他

世界の合成血液代替物及び血液製剤市場の主要な市場プレーヤーは以下のとおりです。
・Aurum Biosciences Ltd、Hemarina SA、KaloCyte Inc.、NuvOx Pharma LLC、Northfield Laboratories、Dentritech, Inc.、HemoBioTech, Inc.、Dextro-Sang Corp.、Baxter International、FluorO2 Therapeutics、Alpha Therapeutic Corp.、Hemoglobin Oxygen Therapeutics LLC、SpheriTech Ltd、Sangart, Inc.、BioPure

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、合成血液代替物及び血液製剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な合成血液代替物及び血液製剤メーカーの企業概要、2019年～2022年までの合成血液代替物及び血液製剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な合成血液代替物及び血液製剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別合成血液代替物及び血液製剤の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの合成血液代替物及び血液製剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での合成血液代替物及び血液製剤市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および合成血液代替物及び血液製剤の産業チェーンを掲載しています。
・第13、14、15章では、合成血液代替物及び血液製剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 合成血液代替物及び血液製剤の概要
- 種類別分析（2017年vs2021年vs2028年）：ヒト血液、動物血液、微生物、合成高分子、幹細胞、その他
- 用途別分析（2017年vs2021年vs2028年）：病院・診療所、血液銀行、その他
- 世界の合成血液代替物及び血液製剤市場規模・予測
- 世界の合成血液代替物及び血液製剤生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Aurum Biosciences Ltd、Hemarina SA、KaloCyte Inc.、NuvOx Pharma LLC、Northfield Laboratories、Dentritech, Inc.、HemoBioTech, Inc.、Dextro-Sang Corp.、Baxter International、FluorO2 Therapeutics、Alpha Therapeutic Corp.、Hemoglobin Oxygen Therapeutics LLC、SpheriTech Ltd、Sangart, Inc.、BioPure
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ヒト血液、動物血液、微生物、合成高分子、幹細胞、その他
・用途別分析2017年-2028年：病院・診療所、血液銀行、その他
・合成血液代替物及び血液製剤の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・合成血液代替物及び血液製剤のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・合成血液代替物及び血液製剤のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・合成血液代替物及び血液製剤の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・合成血液代替物及び血液製剤の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Synthetic Blood Substitutes and Blood Product market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Synthetic Blood Substitutes and Blood Product market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospitals and Clinics accounting for % of the Synthetic Blood Substitutes and Blood Product global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Human Blood segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Synthetic Blood Substitutes and Blood Product include Aurum Biosciences Ltd, Hemarina SA, KaloCyte Inc., NuvOx Pharma LLC, and Northfield Laboratories, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Synthetic Blood Substitutes and Blood Product market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Human Blood
Animal Blood
Microorganisms
Synthetic Polymers
Stem Cells
Others
Market segment by Application can be divided into
Hospitals and Clinics
Blood Banks
Others
The key market players for global Synthetic Blood Substitutes and Blood Product market are listed below:
Aurum Biosciences Ltd
Hemarina SA
KaloCyte Inc.
NuvOx Pharma LLC
Northfield Laboratories
Dentritech, Inc.
HemoBioTech, Inc.
Dextro-Sang Corp.
Baxter International
FluorO2 Therapeutics
Alpha Therapeutic Corp.
Hemoglobin Oxygen Therapeutics LLC
SpheriTech Ltd
Sangart, Inc.
BioPure
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Synthetic Blood Substitutes and Blood Product product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Synthetic Blood Substitutes and Blood Product, with price, sales, revenue and global market share of Synthetic Blood Substitutes and Blood Product from 2019 to 2022.
Chapter 3, the Synthetic Blood Substitutes and Blood Product competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Synthetic Blood Substitutes and Blood Product breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Synthetic Blood Substitutes and Blood Product market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Synthetic Blood Substitutes and Blood Product.
Chapter 13, 14, and 15, to describe Synthetic Blood Substitutes and Blood Product sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Synthetic Blood Substitutes and Blood Product Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Synthetic Blood Substitutes and Blood Product Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Human Blood
1.2.3 Animal Blood
1.2.4 Microorganisms
1.2.5 Synthetic Polymers
1.2.6 Stem Cells
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Synthetic Blood Substitutes and Blood Product Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals and Clinics
1.3.3 Blood Banks
1.3.4 Others
1.4 Global Synthetic Blood Substitutes and Blood Product Market Size & Forecast
1.4.1 Global Synthetic Blood Substitutes and Blood Product Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Synthetic Blood Substitutes and Blood Product Sales in Volume (2017-2028)
1.4.3 Global Synthetic Blood Substitutes and Blood Product Price (2017-2028)
1.5 Global Synthetic Blood Substitutes and Blood Product Production Capacity Analysis
1.5.1 Global Synthetic Blood Substitutes and Blood Product Total Production Capacity (2017-2028)
1.5.2 Global Synthetic Blood Substitutes and Blood Product Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Synthetic Blood Substitutes and Blood Product Market Drivers
1.6.2 Synthetic Blood Substitutes and Blood Product Market Restraints
1.6.3 Synthetic Blood Substitutes and Blood Product Trends Analysis
2 Manufacturers Profiles
2.1 Aurum Biosciences Ltd
2.1.1 Aurum Biosciences Ltd Details
2.1.2 Aurum Biosciences Ltd Major Business
2.1.3 Aurum Biosciences Ltd Synthetic Blood Substitutes and Blood Product Product and Services
2.1.4 Aurum Biosciences Ltd Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Hemarina SA
2.2.1 Hemarina SA Details
2.2.2 Hemarina SA Major Business
2.2.3 Hemarina SA Synthetic Blood Substitutes and Blood Product Product and Services
2.2.4 Hemarina SA Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 KaloCyte Inc.
2.3.1 KaloCyte Inc. Details
2.3.2 KaloCyte Inc. Major Business
2.3.3 KaloCyte Inc. Synthetic Blood Substitutes and Blood Product Product and Services
2.3.4 KaloCyte Inc. Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 NuvOx Pharma LLC
2.4.1 NuvOx Pharma LLC Details
2.4.2 NuvOx Pharma LLC Major Business
2.4.3 NuvOx Pharma LLC Synthetic Blood Substitutes and Blood Product Product and Services
2.4.4 NuvOx Pharma LLC Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Northfield Laboratories
2.5.1 Northfield Laboratories Details
2.5.2 Northfield Laboratories Major Business
2.5.3 Northfield Laboratories Synthetic Blood Substitutes and Blood Product Product and Services
2.5.4 Northfield Laboratories Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Dentritech, Inc.
2.6.1 Dentritech, Inc. Details
2.6.2 Dentritech, Inc. Major Business
2.6.3 Dentritech, Inc. Synthetic Blood Substitutes and Blood Product Product and Services
2.6.4 Dentritech, Inc. Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 HemoBioTech, Inc.
2.7.1 HemoBioTech, Inc. Details
2.7.2 HemoBioTech, Inc. Major Business
2.7.3 HemoBioTech, Inc. Synthetic Blood Substitutes and Blood Product Product and Services
2.7.4 HemoBioTech, Inc. Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Dextro-Sang Corp.
2.8.1 Dextro-Sang Corp. Details
2.8.2 Dextro-Sang Corp. Major Business
2.8.3 Dextro-Sang Corp. Synthetic Blood Substitutes and Blood Product Product and Services
2.8.4 Dextro-Sang Corp. Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Baxter International
2.9.1 Baxter International Details
2.9.2 Baxter International Major Business
2.9.3 Baxter International Synthetic Blood Substitutes and Blood Product Product and Services
2.9.4 Baxter International Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 FluorO2 Therapeutics
2.10.1 FluorO2 Therapeutics Details
2.10.2 FluorO2 Therapeutics Major Business
2.10.3 FluorO2 Therapeutics Synthetic Blood Substitutes and Blood Product Product and Services
2.10.4 FluorO2 Therapeutics Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Alpha Therapeutic Corp.
2.11.1 Alpha Therapeutic Corp. Details
2.11.2 Alpha Therapeutic Corp. Major Business
2.11.3 Alpha Therapeutic Corp. Synthetic Blood Substitutes and Blood Product Product and Services
2.11.4 Alpha Therapeutic Corp. Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Hemoglobin Oxygen Therapeutics LLC
2.12.1 Hemoglobin Oxygen Therapeutics LLC Details
2.12.2 Hemoglobin Oxygen Therapeutics LLC Major Business
2.12.3 Hemoglobin Oxygen Therapeutics LLC Synthetic Blood Substitutes and Blood Product Product and Services
2.12.4 Hemoglobin Oxygen Therapeutics LLC Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 SpheriTech Ltd
2.13.1 SpheriTech Ltd Details
2.13.2 SpheriTech Ltd Major Business
2.13.3 SpheriTech Ltd Synthetic Blood Substitutes and Blood Product Product and Services
2.13.4 SpheriTech Ltd Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Sangart, Inc.
2.14.1 Sangart, Inc. Details
2.14.2 Sangart, Inc. Major Business
2.14.3 Sangart, Inc. Synthetic Blood Substitutes and Blood Product Product and Services
2.14.4 Sangart, Inc. Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 BioPure
2.15.1 BioPure Details
2.15.2 BioPure Major Business
2.15.3 BioPure Synthetic Blood Substitutes and Blood Product Product and Services
2.15.4 BioPure Synthetic Blood Substitutes and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Synthetic Blood Substitutes and Blood Product Breakdown Data by Manufacturer
3.1 Global Synthetic Blood Substitutes and Blood Product Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Synthetic Blood Substitutes and Blood Product
3.4 Market Concentration Rate
3.4.1 Top 3 Synthetic Blood Substitutes and Blood Product Manufacturer Market Share in 2021
3.4.2 Top 6 Synthetic Blood Substitutes and Blood Product Manufacturer Market Share in 2021
3.5 Global Synthetic Blood Substitutes and Blood Product Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Synthetic Blood Substitutes and Blood Product Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Synthetic Blood Substitutes and Blood Product Market Size by Region
4.1.1 Global Synthetic Blood Substitutes and Blood Product Sales in Volume by Region (2017-2028)
4.1.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Region (2017-2028)
4.2 North America Synthetic Blood Substitutes and Blood Product Revenue (2017-2028)
4.3 Europe Synthetic Blood Substitutes and Blood Product Revenue (2017-2028)
4.4 Asia-Pacific Synthetic Blood Substitutes and Blood Product Revenue (2017-2028)
4.5 South America Synthetic Blood Substitutes and Blood Product Revenue (2017-2028)
4.6 Middle East and Africa Synthetic Blood Substitutes and Blood Product Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Synthetic Blood Substitutes and Blood Product Sales in Volume by Type (2017-2028)
5.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Type (2017-2028)
5.3 Global Synthetic Blood Substitutes and Blood Product Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Synthetic Blood Substitutes and Blood Product Sales in Volume by Application (2017-2028)
6.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Application (2017-2028)
6.3 Global Synthetic Blood Substitutes and Blood Product Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Synthetic Blood Substitutes and Blood Product Sales by Type (2017-2028)
7.2 North America Synthetic Blood Substitutes and Blood Product Sales by Application (2017-2028)
7.3 North America Synthetic Blood Substitutes and Blood Product Market Size by Country
7.3.1 North America Synthetic Blood Substitutes and Blood Product Sales in Volume by Country (2017-2028)
7.3.2 North America Synthetic Blood Substitutes and Blood Product Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Synthetic Blood Substitutes and Blood Product Sales by Type (2017-2028)
8.2 Europe Synthetic Blood Substitutes and Blood Product Sales by Application (2017-2028)
8.3 Europe Synthetic Blood Substitutes and Blood Product Market Size by Country
8.3.1 Europe Synthetic Blood Substitutes and Blood Product Sales in Volume by Country (2017-2028)
8.3.2 Europe Synthetic Blood Substitutes and Blood Product Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Synthetic Blood Substitutes and Blood Product Sales by Type (2017-2028)
9.2 Asia-Pacific Synthetic Blood Substitutes and Blood Product Sales by Application (2017-2028)
9.3 Asia-Pacific Synthetic Blood Substitutes and Blood Product Market Size by Region
9.3.1 Asia-Pacific Synthetic Blood Substitutes and Blood Product Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Synthetic Blood Substitutes and Blood Product Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Synthetic Blood Substitutes and Blood Product Sales by Type (2017-2028)
10.2 South America Synthetic Blood Substitutes and Blood Product Sales by Application (2017-2028)
10.3 South America Synthetic Blood Substitutes and Blood Product Market Size by Country
10.3.1 South America Synthetic Blood Substitutes and Blood Product Sales in Volume by Country (2017-2028)
10.3.2 South America Synthetic Blood Substitutes and Blood Product Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Synthetic Blood Substitutes and Blood Product Sales by Type (2017-2028)
11.2 Middle East & Africa Synthetic Blood Substitutes and Blood Product Sales by Application (2017-2028)
11.3 Middle East & Africa Synthetic Blood Substitutes and Blood Product Market Size by Country
11.3.1 Middle East & Africa Synthetic Blood Substitutes and Blood Product Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Synthetic Blood Substitutes and Blood Product Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Synthetic Blood Substitutes and Blood Product and Key Manufacturers
12.2 Manufacturing Costs Percentage of Synthetic Blood Substitutes and Blood Product
12.3 Synthetic Blood Substitutes and Blood Product Production Process
12.4 Synthetic Blood Substitutes and Blood Product Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Synthetic Blood Substitutes and Blood Product Typical Distributors
13.3 Synthetic Blood Substitutes and Blood Product Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 合成血液代替物及び血液製剤の世界市場2022：ヒト血液、動物血液、微生物、合成高分子、幹細胞、その他(Global Synthetic Blood Substitutes and Blood Product Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

合成血液代替物及び血液製剤の世界市場2022：ヒト血液、動物血液、微生物、合成高分子、幹細胞、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp